Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BN Covid-19 vaccines
J07BN01 Covid-19, RNA-based vaccine
D12114 Elasomeran (JAN) <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Vaccines
COVID-19
COVID-19 Vaccine (mRNA)
D12114 Elasomeran (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
631 Vaccines
6313 Viral vaccines
D12114 Elasomeran (JAN); Andusomeran (JAN); Elasomeran (JAN) and imelasomeran (JAN); Elasomeran (JAN) and davesomeran (JAN)
Drug groups [BR:br08330]
Antiviral
DG03172 COVID-19 vaccine
D12114 Elasomeran
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12114
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12114
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12114
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12114